priyaraut's blog

Opioids are medications prescribed by doctors and physicians to treat various levels of pain. These can include acute pain and chronic non-cancer pain. They are also known as painkillers and used to block pain signals from the brain. Market Research Future (MRFR) has stressed the advantages of the intake of opioids as well as the efforts by manufacturers to address various issues concerning the drugs. 

Growth Drivers

The opioids market is expected to reach USD 6,060.17 million at CAGR of 4.90% during the forecast period 2022-2030. Pain management of various chronic diseases remain the primary driver of the market. According to the National Institute of Drug Abuse, nearly 200 million prescriptions were dispensed by U.S. pharmacies in 2017. The large number of prescriptions is an indicator for the large scope of the market.

Favorable reimbursement schemes for covering the costs of opioids in palliative care can work in favor of the market. Large number of patients diagnosed with various cancers can drive the market demand for opioids till 2023. Rise in surgical procedures and road accidents are other factors which can contribute to market demand due to the need for pain relievers. All of these factors are predicted to push the market to exhibit a CAGR of 7.12% during the forecast period. 

Establishment of new guidelines to curb the intake of opioids and reduce the addiction rates are expected to disrupt the market in a positive manner. For instance, the sale of over-the-counter drugs containing opioids is restricted, while stringent measures are undertaken regarding prescriptions given by doctors. New policies by government-supported insurance companies such as Medicare are limiting the dispensation rate of opioids to 7 days.

But misuse of viatris opioids and adverse effects of the drugs which lead to addiction threaten the market growth. 

Segments In-Detail:

MRFR has segmented the global opioids market by product, application, and end-user. 

Based on the product, the market is segmented into immediate release/short-acting opioid and extended release/long-acting opioid. Extended release comprises hydromorphone, oxycodone, morphine, oxymorphone, and others. The extended release segment had accounted for USD 12,750.91 million in 2017. This segment can expand in the coming years due to rising prevalence of chronic diseases.

By application, it is segmented into diarrhea suppression, deaddiction, cough suppression, pain relief, anesthesia, and others. The pain relief segment is expected to be the dominant application of the opioids market due to rise in pain management therapies. Moreover, new guidelines for selling prescription drugs coupled with rise in palliative and end-of-life care can boost segment growth. This in turn can drive the market demand exponentially.

By end-user, the market caters to academic research institutes, hospitals & clinics, and pharmacies.

Regional Analysis:

MRFR’s report takes a deep look into major regions which include the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). 

The Americas is predicted to be dominant in the global market due to holding the largest market share due to awareness among patients and the high intake of the drugs for pain alleviation. On the other hand, Europe is expected to showcase prolific growth due to rise in palliative care centers and strict regulations regarding opioid usage.

A Look at the Competition:

Prominent companies operating in the opioids market players include Janssen Global Services, LLC, Egalet Corporation, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi SA, Purdue Pharma L.P, Boehringer Ingelheim GmbH, Allergan Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt, Vertice Pharma LLC, and West-Ward Pharmaceuticals Corporation. 

New in Research

Opioid-induced constipation is on the rise due to being one of the side-effects during intake of pain relievers. In 2019, Novartis has agreed to partner with Shinogi & Co Ltd, for bringing to market Rizmoic in selected areas of the Netherlands, the U.K., and Germany.

According to a study published by the researchers at the University of Pennsylvania School of Medicine, patients in the United States and Canada are more likely to procure opioids due to the large number of chronic diseases. High prevalence of minimally invasive surgeries and prescription of codeine in post-operative care can bode well for the global opioids market in the coming years.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Sep 19 '23 · 0 comments · Tags: opioids market

Market Analysis
Dental Biomaterials Market Overview, by Type, by Application, by End User, Forecast till 2030. The dental biomaterials market is anticipated to reach USD 8720.26 Million by 2030 at 5.9% CAGR during the forecast period 2022-2030, reveals the new Market Research Future (MRFR) report. Dental biomaterials, simply put, are natural or fabricated structures that are utilized in dentistry for orthodontics, prosthodontics, implantology, and others. 

Various factors are propelling the dental biomaterials market growth. Such factors, as per the latest Market Research Future report, include the growing awareness about the significance of dental implants, rise in disposable income, rising investments in the dental industry, and growing dental tourism. Additional factors pushing the growth of the dental biomaterials market include increasing dental expenditure and increasing incidence of dental trauma and dental caries. 

On the contrary, scarcity of dental professionals, presence of strict clinical and regulatory processes, reported cases of peri-implant and peri-implantitis mucositis, and the soaring cost of implants are factors that may deter the dental biomaterials market growth during the forecast period.

Market Segmentation

The Market Research Future report provides an all-inclusive segmental analysis of the dental biomaterials market on the basis of end user, type, and application.

By type, the dental biomaterials market is segmented into natural biomaterials, metal-ceramic biomaterials, polymeric biomaterials, ceramic biomaterials, and metallic biomaterials. The metallic biomaterials segment is again segmented into chromium alloys, stainless steel, titanium, and others. Of these, metallic biomaterials will dominate the market during the forecast period. Various factors propelling the growth of the segment include its extensive applications in dentistry and rising penetration of dental implants. 

By application, the dental biomaterials market is segmented into orthodontics, prosthodontics, implantology, and others. Of these, the implantology segment will have the maximum share in the market during the forecast period. Various factors propelling the growth of the segment include the rising disposable income, growing dental tourism, bourgeoning demand for cosmetic dentistry, growing prevalence of dental diseases, high volume needs, and price of titanium used to manufacture dental implants, and rising penetration of dental implants worldwide. 

By end users, the dental biomaterials market is segmented into research institutes, dental academics, dental hospitals & clinics, dental laboratories, and dental product manufacturers. Of these, dental product manufacturers will lead the market during the forecast period. Various factors propelling the growth of the segment include the growing awareness of oral diseases, rising number of dental practices, growing adoption of CAM/CAD systems in laboratories and dental clinics, and increasing penetration of dental implants as well as prosthetics. 

 Regional Analysis

By region, the dental biomaterials market research report covers the latest trends and growth opportunities across the Americas, the Asia Pacific, the Middle East and Africa, and Europe. Of these, the Americas will lead the market during the forecast period. Factors pushing the growth of the dental biomaterials market in the region include evolving dental care infrastructure, highest diabetic population, early adoption of latest dental biomaterials, mounting prevalence and awareness of dental disorders, high dental expenditure, and presence of notable players in the region. China, as well as India, are the major contributors in the region.

The dental biomaterials market in Europe will have the second-largest share in the market during the forecast period. Factors pushing the growth of the dental biomaterials market in the region include rising government funding on oral healthcare, rising number of dental procedures, presence of various developed economies, increase in dental hospitals & clinics, growing geriatric population, and increasing use of dental biomaterials for manufacturing implants as well as other dental products. 

The dental biomaterials market in the APAC region will grow at the fastest pace during the forecast period. Factors pushing the growth of the dental biomaterials market in the region include growing awareness about oral health coupled with the rapidly developing dental industries. 

The dental biomaterials market in the MEA will have a minimal share during the forecast period owing to low healthcare expenditure, lack of awareness, and the presence of poor economies. 

Key Players

Notable players profiled in the dental biomaterials market report include Cam Bioceramics BV, Bego Medical GmbH, Datum Dental Ltd, Keystone Dental, Inc., GC Corporation, Ivoclar Vivadent AG, Victrex PLC, Mitsui Chemicals, Inc., Henry Schein, Inc., Medtronic PLC, Kuraray Co., Ltd, Carpenter Technology Corporation, Royal DSM, 3M Company, Dentsply Sirona, Inc., Danaher Corporation, Zimmer Biomet Holdings, Inc., Geistlich Pharma AG, and Straumann Holding AG. Key players have incorporated different strategies for sustaining the competitive environment, such as research and development for advancements in dental biomaterials, product approvals and product launches. 

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Sep 19 '23 · 0 comments · Tags: dental biomaterials market

Clinical alarm management systems are likely to gain quick mileage in the foreseeable future. It has been assessed in a report published by Market Research Future (MRFR) that The clinical alarm management market size was valued USD 1.02 billion in 2021 and is expected to reach USD 5.35 billion by 2030 at 31.30% CAGR during the forecast period 2022-2030. These systems are non-invasive and send a warning to the doctors and nurses in case of emergencies. Increasing patient population is likely to fuel demand for these systems as it ensures efficiency and quick response to emergencies. 

The rising burden of chronic diseases has propelled the expansion of the clinical alarm management market and is poised to demonstrate a similar pattern in the years to come. Technological innovations by the key players are further expected to generate more demand in the nearby future, thus, catalyzing the growth of the global clinical alarm management market. It is also highlighted that the rising adoption of technology in the healthcare sector is benefitting the expansion of the clinical alarm management market over the next couple of years. However, factors such as sleep disruption and noise fatigue are anticipated to undermine the growth pace of the clinical alarm management market in the foreseeable future.

Regional Analysis:

For an extensive geographical assessment of the global clinical alarm management market, it has been segmented into four major regions – Americas, Europe, the Middle East & Africa (MEA), and Asia Pacific. Americas is currently holding the largest market share and is anticipated to maintain its prominence over the next couple of years. The developed healthcare infrastructure of the region is providing impetus to the expansion of the clinical alarm management market. Europe is poised to maintain its position at the second spot and is anticipated to benefit from the government support and funds. Asia Pacific clinical alarm management market is projected to register the highest CAGR over the assessment period. 

Market Segmentation:

The different segments, on the basis of products, identified in this study on the clinical alarm management market insights are segmented nurse call systems, EMR integration systems, physiological monitors, bed alarms, mobility solutions, ventilators, central monitoring systems, and clinical decision support tools.

The different components of the global clinical alarm management market assessed in this MRFR report are solutions and services.

On the basis of the end-user, the clinical alarm management market has been segmented into hospitals, ambulatory care centers & home care settings, and long-term care centers.

Competitive Dashboard:

The market exhibits robust competition among the key players on account of technological advancements. Since the technology is gaining momentum among the healthcare providers, participants in the global clinical alarm management market are anticipated to introduce innovative technologies for staying ahead of the curve. In addition, investments are expected to be increased in research and development for the development of product portfolios. This, in turn, is expected to impact revenue generation of the noted vendors favorably in the years to come.

Koninklijke Philips N.V., Vocera Communications, Medtronic, Baxter, Mindray Medical International, Ascom Holdings, Spok, Inc. (Subsidiary of Spok Holdings, Inc.), GE Healthcare, Masimo, Connexall, Drager, Capsule Technologie (Subsidiary of Qualcomm Life, Inc.), Bernoulli Enterprise, Inc., and Mobile Heartbeat (Subsidiary of Hospital Corporation of America) are some of the main players of the global clinical alarm management market and are poised to earn massive revenue in the upcoming years.

The market is also projected to make way for the entry of new players owing to the increasing number of technology startups venturing into the healthcare sector. The most promising strategies being adopted by the market participants for ensuring market growth are mergers & acquisitions, partnerships, product development, collaboration, etc.

 

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Insights

The global fetal bovine serum market is presumed to soar high during the forecast period 2018-2023 owing to the advancements in research and academic initiatives by the private and governmental sector. Market Research Future Reports published their latest report on the global Fetal Bovine Serum Market Share was valued at USD 0.9 billion in 2022 and is projected to grow from USD 0.95 Billion in 2023 to USD 1.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.60% during the forecast period (2023 - 2030). 

Fetal bovine serum is a by-product from the beef industry and is a crucial raw material for animal health, biotechnology, pharmaceutical research, and diagnostic as well as other research areas.

Global Fetal Bovine Serum Market: Drivers & Trends

Increase in academic research institutes globally is driving the demand for fetal bovine serum. There have been various governments bodies who are collaborating with academic research institutes to support research activities in pharmaceutical, biotechnology, diagnostics, and veterinary industries as the fetal bovine serum is an essential element for the development of drug and having wide applications in cell-based pharmaceutical research. 

Also, fetal bovine serum (FBS) is also considered to be the most widely used in the growth of cell culture media owing to its high content of embryonic procedures. These abilities of fetal bovine serum are driving to the growth of global fetal bovine serum market. Thus, when it is used at appropriate concentrations, it tends to supply many defined and undefined components that satisfy specific metabolic requirements for the culture of cells.

On the other hand, the advancement in research and academic initiatives by researches is also expected to drive the market growth in positive ways. There has also been observed that the surge in demand from traditional users of serum is also encouraging the market to operate in the years to come. Even the government bodies are investing in more extensive ways to promote and support research activities. This, in turn, is motivating to accelerate the growth of the global fetal bovine serum market in the years to come.

Global Fetal Bovine Serum Market Segmentation

According to the reports published by Market Research Future Reports has mentioned that the global fetal bovine serum market outlook has been segmented by product type, application, and end user.

Wherein, the fetal bovine serum market, by product type is segmented into charcoal stripped, chromatographic, Dialyzed Fetal Bovine Serum (FBS), exosome depleted, stem cell, and others. Added to this, the stem cell is further segmented into embryonic stem cells qualified, and mesenchymal stem cell qualified.

By the mode of application, the fetal bovine serum market has been segmented into drug discovery, cell culture media, in-vitro fertilization, human & animal vaccine production, diagnostics, and others.

By the mode of end user, the market is segmented into research & academic institutes, pharmaceutical, biotechnology, and others.

Regional Outlook 

Region wise, the global fetal bovine serum market has covered the main regions such as Americas, Europe, Asia-Pacific, and the Middle East and Africa. 

It has been observed that North America leads the global fetal bovine serum market owing to the growth of the market in rapid pace attributing to the factors such as an increase in funding events for research, and growing awareness about the high-end fetal bovine serum among medical professionals.

Whereas, Europe currently owes a considerable amount of market share in the fetal bovine serum market. It is observed that, in the near future, the region will predict with exhibiting declination in growth due to emerging ethical issues and religious sentiments about animal-derived products. Such a situation would result in a low market share over the forecast period.

Asia-Pacific is also projected to be the fastest growing region for the global fetal bovine serum market owing to the infrastructural development and increase in outsourcing of research activities to the contract research organizations (CROs) at relatively low cost.

On the other hand, the Middle East and Africa grasp the least share in the global fetal bovine serum market owing to the presence of economically diverse countries, and scarcer initiatives from the government.

Key Players

Market Research Future Reports have listed the names of some of the crucial market players of the global fetal bovine serum market. The names are as follows, HiMedia Laboratories, Merck KGaA, Bovogen Biologicals Pty Ltd, Atlanta Biologicals Inc., TCS Biosciences Ltd, Tissue Culture Biologicals, Rocky Mountain Biologicals, GE Healthcare, Thermo Fisher Scientific, Bio-Techne, PAN-Biotech, Access Biologicals, Animal Technologies Inc., Nucleus Biologics, Biological Industries, Corning Incorporated

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Sep 19 '23 · 0 comments · Tags: fetal bovine serum market

The Arterial Blood Collection Market is projected to reach USD 1924.34 million by 2030 at 10.2% CAGR during the forecast period 2022-2030. The rise in diagnostic procedures is shaping the demand for the arterial blood collection devices market positively. Reports that evaluate the medical device industry have been made accessible by Market Research Future, which creates reports on several industry verticals that review the market development and prospects. The market is poised to achieve a CAGR of 9.1% while amassing income worth USD 1,624.6 million by the conclusion of the forecast in 2023.

The expansion of the diagnostic sector is expected to create momentum for the expansion of the market. Moreover, the increased detection rate of chronic ailments is expected to encourage the progress of the arterial blood collection devices market. The escalated investment being dedicated to research and development in the arterial blood collection devices market is estimated to benefit long-term growth.

Segmental Analysis

The segmental evaluation of the arterial blood collection devices market is carried out on the basis of type, application, end user, and region. Based on type, the market for arterial blood collection devices is segmented into microfluidic system, lancet, needles, blood collection tubes, vacuum blood collection system, and other devices. By application, the arterial blood collection market is segmented into intraoperative blood salvage and arterial blood gas sampling. The arterial blood gas sampling is further sub-segmented into acid base status monitoring and diagnosis of disease. The end-user based segmentation of the arterial blood collection devices market comprises of hospitals & clinics, blood banks, laboratories, and others. Based on the regions, the arterial blood collection devices market comprises of Europe, the Americas, APAC, and the Middle East & Africa.

Detailed Regional Analysis     

The regional assessment of the arterial blood collection devices market includes regions such as Europe, the Americas, APAC, and the Middle East & Africa. The Americas is responsible for a substantial market share in 2016, as a result of growing prevalence of chronic diseases, increasing emphasis on safe blood transfusion processes the concentration of major market players producing blood collection devices, and widespread demand for diagnostic services.The European region is the second principal market and holds a significant share in the arterial blood collection devices market. The availability of funds from the government for research and development is anticipated to contribute to the development of the market. The increased demand for diagnostic services in the Asia Pacific region is a significant factor for market development. Increasing awareness about the use of sterile blood collection devices and an escalating number of surgical procedures are driving the market in the Asia Pacific region.The Middle East and African region are anticipated to display steady growth in this market owing to the growing prevalence of transmissible transfusion infections and the demand for medical devices for diagnostics. The government has also commenced awareness programs for safe blood transfusion procedure, which is additionally improving the health conditions in the underdeveloped regions of Africa.

Competitive Analysis

Amplified investment in the market is likely to motivate the positive changes in the market in the forecast period. The decrease in trade restrictions is anticipated to create favorable opportunities for development in the forecast period. The presence of favorable trade policies is anticipated to improve the growth of the market in the impending period. Strong insights into the market’s condition is motivating the expansion of the forecast period. The offering in the market has also diversified considerably ensuring availability of better-quality products in the market. The emergence of specialization in production has also increasingly improved the growth trajectory of the market. The efficiencies achieved in the allocation of resources is expected to encourage the development of the market in the approaching period. Moreover, increased cost efficiencies are projected to positively impact the progress of the market in the coming years.

The chief contenders in the artificial blood collection devices market are Terumo Medical Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S), Becton, Dickinson and Company (U.S), Qiagen (Netherlands), NIPRO Medical Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific, Inc. (U.S) and others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013,

United States of America

The importance of beauty and personal appearance currently is at an all-time high as compared to earlier times due to the development of social media proliferation, thus boosting the Asia Pacific Aesthetics Market. Reportscreated by MRFR detail the developments in the industry that can be expected in the market through the forecast period. The Asia Pacific Aesthetics market size is projected to reach USD 4.3 Billion by 2032 at 9.9% CAGR during the forecast period 2023-2032. 

The breakthroughs in non-invasive procedures due to advancements in technology are estimated to further influence the Asia Pacific Aesthetics Market expansion. Moreover, the heightened level of affluence in the end-user base is estimated to contribute to the Asia Pacific Aesthetics Market share in the upcoming period.

Prominent Companies

ZELTIQ Aesthetics Inc. (U.S.), Galderma S.A. (Switzerland), Alma Lasers (Israel), Lumenis (Israel), PhotoMedex, Inc.  (U.S.), Cutera (U.S.), Johnson & Johnson Services, Inc. (U.S.), Solta Medical, Inc. (Canada), Syneron Medical Ltd. (U.S.), Mentor Worldwide LLC (U.S), Merz Pharma (Germany), Integra Lifesciences (U.S.), Cynosure Inc. (U.S.), ALLERGAN (Ireland), Sanofi (France), are some of the leading companies in the Asia Pacific aesthetics market.

Market Segmentation

The Asia Pacific aesthetics market has been segmented on the basis of procedures, products, application, and end-user.

The various procedures in the market are surgical aesthetic procedures and nonsurgical aesthetic procedures. The surgical aesthetic procedures are categorized into liposuction, breast augmentation, tummy tuck, eyelid surgery, breast lift, dermabrasion, and others. On the other hand, the nonsurgical aesthetic procedures are split into the segments of botulinum toxin, hyaluronic acid, hair removal, photorejuvenation (IPL), chemical peel, microdermabrasion, and others.

Product-wise, the market caters to laser and energy-based devices, skin tightening and body contouring devices, aesthetic implants, and others. The types of skin tightening and body contouring devices are liposuction devices, cellulite reduction devices, cryolipolysis technology, anti-aging device, and others. The aesthetic implants are fragmented into dental implants, breast implants, buttock augmentation, transdermal implants, and others.

The various applications are facial & body contouring, facial & skin rejuvenation, breast enhancement, scar treatment, reconstructive surgery, tattoo removal, malignant ascites, vaginal rejuvenation, and so on.

Depending on end-user, the market can be segmented based on hospitals & clinics, dermatology clinics, cosmetic centers, and others.

Detailed Regional Analysis 

The regional scrutiny of the Asia Pacific Aesthetics Market Insights consists of North America, Europe, Africa, and the Middle East. The North American region’s Asia Pacific Aesthetics Market is estimated to emerge as the principal regional market in the overall Americas region. The aesthetic industry growth in the North American region is the outcome of the speedy development in beauty treatments and various anti-aging cosmetic operations. The Mexican aesthetic devices market in the region has been bolstered by the mounting interest in cosmetic techniques, improving healthcare infrastructure, intensifying problem of skin illnesses, and the increasing number of accomplished board-certified cosmetic doctors. The regional market of Europe is promoted to be the next highest gainer in the worldwide market in the future, supported by the collective support given by the government and the great population of elderly patients who need improvement in physical form. The substantial healthcare expenditure is another development-inducing influence in the regional market. The APAC regional market is estimated to be driven due to the exploding patient population, swift innovations in technology, and the profusion of lucrative prospects for global companies in the region. The UAE aesthetic devices market in the Middle Eastern region is mounting at an encouraging rate, because of the rising surgeries counting facial fat grafting, breast enlargement, liposuction, and more. The need for innovative devices and tools to ensure safer and more effective procedures are projected to guide the Asia Pacific Aesthetics Market in the region.

Competitive Analysis

The funding scenario in the market is estimated to be optimistic and conducive to the development of the stakeholders in the market. The government policies in several regions are very conducive to the development of the market in the upcoming period. The advancement of production technology and processes is estimated to augment the global market. The establishment of clear long-term objectives by market titans is estimated to set the tone for the continuing expansion of the market. The identification of areas for sustainable enhancement in the supply chain is estimated to further fortify the market. The advancement of the market is spurred by the initiatives of the leaders in the global market, who are dedicating resources to the development of the overall market. The scale of innovation being observed in the market is another reason that is adding to the advancement of the global market in the future. The detrimental impact on the environment by the business practices is estimated to be a key component in the future growth strategies of the market.

 

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future (MRFR) has published a research report about the global neurovascular devices market size to touch over USD 4.2 Billion by 2030. MRFR also anticipates the global market’s growth to be at a rate of 5.7% during the review period 2022 to 2030. This report talks about the market scenario and future prospects regarding growth. In this report, the global neurovascular devices market has been segmented on the basis of end-user, product, therapeutic application, and lastly region. 

Problems related to the nervous system are serious. They cannot be seen easily, and their therapies usually lie in surgeries where patients and doctors need to decide which surgeries are more invasive and which are less invasive. Neurovascular devices are necessary for treating neurovascular diseases. These devices have been developed due to demand for minimally invasive procedures. There has never been a dearth of neurovascular patients. Therefore, the global neurovascular devices market has huge scope for growth. Factors contributing to the growth of this market include favorable reimbursement policies, and ongoing product development & commercialization.

On the basis of the end-users, this market has been segmented into ambulatory surgical units and hospitals & clinics. Ambulatory surgical units work for ambulatory surgery centers (ASC) that are also known as outpatient surgery centers, same-day surgery centers, or surgicenters. Ambulatory surgical units perform surgical procedures not requiring an overnight hospital stay. Such surgery is commonly less complicated than those required hospitalization. 

Key Players

The key players in the global neurovascular devices market include Abbott Laboratories (USA), Blockade Medical LLC. (France),  Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA), Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan), Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc. (USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA), Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates, Inc. (USA).

Segmentation:

The product-based segmentation segments the Neurovascular Devicesmarket insights into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, neurovascular catheters, neuro thrombectomy devices, and a support device. The aneurysm coiling & embolization devices segment has been sub-segmented into embolic coils, flow diversion devices, and liquid embolic. Embolic coils block blood flow into an aneurysm (weak area of an artery). The embolic protection systems have been segmented into balloon occlusion devices and distal filter devices. Cerebral angioplasty is a procedure useful for opening the partially blocked carotid and vertebral arteries in the neck. They can also do the same for blood vessels within the brain. It has been segmented into is sub-segmented into carotid artery stents and embolic protection systems. Stenting system indicates an improvement of coronary luminal diameter in patients with symptomatic ischemic heart disease. Neurothrombectomy devices are used for treating acute ischemic strokes. They have been sub-segmented into aspiration devices, retrieval systems, and suction devices. Based on therapeutic application, the market has been segmented into the hemorrhagic stroke and ischemic strokes. A hemorrhagic stroke can be defined as either a brain aneurysm burst or a weakened blood vessel leak. The different types of ischemic strokes occur when the body is deprived of oxygen or any other important nutrients.

The regional segmentation of the global neurovascular devices market comprises of The Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA) region. The Americas dominate the global neurovascular devices market due to a large number of patients suffering from neurovascular diseases like arteriovenous malformations (AVMs) and brain aneurysm. Due to technological advancement, high disposable income, and the availability of better medical facilities, North America is the bigger market than South America. Moreover, increasing healthcare expenditure, government aid to researches in the field of medical sciences and the presence of the key players in North America boosts the growth of the market in North America. Majority key players in this region are based in the United States of America (USA). 

Europe holds the second largest share in global neurovascular devices market. Increasing prevalence of the neurovascular diseases and the presence of a well-developed healthcare sector are the major factors that drive the market growth in this region. Due to reasons same as The Americas, Western Europe market is bigger than Eastern Europe. In Europe, most of the key players in this market are based in France and the United Kingdom (UK).

The Asia Pacific region is the fastest growing market for the market due to continuously developing economies like China and India, increasing demands for minimally invasive surgeries by the growing geriatric population, and the presence of a huge patient population. Asia Pacific region is yet to achieve the infrastructure development and technological advancement as par the level of North America and Europe, and there are few countries in this region that are technologically advanced. In the Asia Pacific region, the biggest markets are Australia, China, India, Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a small market due to political instability in most countries due to movements like Arab Spring. Lack of technology and less investment in healthcare due to healthcare not being considered a priority by governments in this region are the reasons for a small market. The biggest markets in this region are Kuwait, Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of MEA region.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Aug 24 '23 · 0 comments · Tags: neurovascular devices market

Surgical Robots Market Overview and analysis By Product Type, By Application, By Control Mechanism, By End-User and Region—Forecast till 2030

The Global Surgical Robots Market is growing with the rapid pace mainly due to the burgeoning Healthcare Industry.  According to a recent study report published by the Market Research Future, The surgical robots market size was valued at USD 4.21 billion in 2021 and is projected to grow from USD 5.05 Billion in 2022 to USD 21.41 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8% during the forecast period (2022 - 2030).

Advancements in technology have empowered surgeons to remotely operate robots and perform surgery. Surgeons can perform a surgical procedure in emergency situations through telesurgery, with the aid of an imaging device. There are many advantages of robotic surgery over traditional open surgery like more accuracy, less pain, small insertions and many more.  Increasing automation in healthcare sector and increasing demand for the minimally-invasive surgeries and more advances robotics has led to growth of this market across the globe. Beside this increasing incident of cancer, different neurological disorders and many more diseases has provided fuel for the growth of the market. Additionally, advancements in technology over the fast few years have been directed towards reducing costs of products. This has led to increasing applications of these robots for various tasks.

While high cost of surgical robots, risks associated with the robotic surgeries and the scepticism toward technology may hamper the growth of the market. Adversely, the development of Surgical robots with high artificial intelligence technology is driving the Surgical robots market. 

Surgical Robots Global Market – Segments

The Surgical Robots Market can be segmented in to 4 key dynamics for the convenience of the report and enhanced understanding; 

Segmentation By Control Mechanism                    : Comprises Direct Telemanipulator and Computer Control.

Segmentation By Robotic Surgery Approach       : Comprises Supervisor-Controlled Robotic Surgical System, Shared Control Robotic Surgical Systems, Telesurgery Systems, Robotic Radiosurgery Systems.

Segmentation By Application                                   : Comprises General Surgery, Cardiac Surgery, Gynecologic Surgery, Colorectal Surgery, Urologic Surgery, Head and Neck Surgery and other.

Segmentation By Regions                                                         : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Surgical Robots Global Market – Competitive Analysis 

Characterized by the presence of well-established players; Surgical Robots market research report appears to be highly competitive. Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position. Vendors are focusing on improving their market performance and are expanding by acquiring promising companies in the fast-growing markets. Marketers employ a continuous improvement strategy to analyze and update the software, implementing improvements and launching new technologies to meet the changing needs of consumer. These manufactures develop a well-established infrastructure that allows seamless implementation of advanced technologies. They strive to develop unravel design and adept technology Heavy investments are transpired in R&D sector from the major players which is in turn helping the market to grow. 

In view of growth and immense revenue generation opportunities potential that market is currently demonstrating is in turn attracting several new players to enter the market. However, those new entrants find it challenging to survive in the market with the introduction of new technologies. 

Surgical Robots Global Market – Regional Analysis

On regional basis, America has the largest market for surgical robots. Availability of finance, well developed healthcare sector with continuous increasing prevalence of number of diseases are the major driving factor for America surgical robots market. North America is the major contributor for the Americas surgical robots market. In 2016, North America surgical robots market was USD 1,655.8 million. Europe has second leading market which is followed by Asia Pacific region. Increasing prevalence of diseases like cancer and many neurological disorder in Europe has help to grow this market. Asia Pacific region is showing slow growth for surgical robot market. Asia Pacific surgical robots market is expected to grow at a CAGR of 23.36 % forecast period from 2017-2023

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Aug 24 '23 · 0 comments · Tags: surgical robots market

Malaria is a life-threatening disease that is transmitted through the bite of infected anopheles mosquitos. The infected mosquitos transmit the plasmodium parasite into the bloodstream of human body upon being bitten. As the parasite enters the human body, it travels around the body to affect the liver and matures with time. Upon attaining maturity, the parasite enters the bloodstream to infect the red blood cells in the body. This causes individuals suffering from malaria to frequently experience headache, vomiting, fever, and weakness. 

The Africa malaria diagnosis & treatment market Research report is projected to reach USD 2,467.6 Million by 2030 at 6.9% CAGR during the forecast period 2022-2030.It is reported in a study released by Market Research Future (MRFR), that the market is positively influenced by a number of factors. A major factor influencing this growth is the increasing advancements in technology related to diagnostic tools and the proliferating demand for such treatments in malaria-endemic countries. Other factors driving the market growth are rising support from the government in terms of investment funds and an increase in the collaboration between the research centers and the industry. Malaria diagnostic tests play a significant role in identifying malarial cases, which thereby boosts the growth of the overall malaria diagnostic market.

However, the lack of precise monitoring standards at developing nations, acts as a major factor constraining the market. The lack of awareness among emerging nations and work regulatory framework is of particular concern for both manufacturers and healthcare providers. 

Market Segmentation

The global malaria diagnostics market segmentation is done as per technology and end-user.

By technology, the market is divided into microscopy, molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the molecular diagnostic test is narrowed down into real-time polymerase chain reaction (RT-PCR) and polymerase chain reaction (PCR).

By end-users, the market comprises of clinics, hospitals, community healthcare, and others.

Regional Analysis

Geographically, the global malaria diagnostic market covers regions such as North America, European, Asia Pacific, and Middle East & Africa. 

The North American region holds the largest share of the malaria diagnostic market and leads the global standings. The region is further expected to garner the largest market share during the forecast period 2018 and 2023. The market is slated for growth due to the rise in awareness, advancing medical technologies, favorable compensation setting for various surgical methods and procedures, medical tourism, and expanding growth of the healthcare sector. 

Competitive Landscape 

The global malaria diagnostics market Trends comprises of a number of key and prominent players, including Leica Microsystems GmbH, Premier Medical Corporation Pvt. Ltd, Access Bio. Inc., Beckman Coulter Inc., bioMérieux, Nikon Corporation, Abbott Laboratories, Olympus Corporation, Sysmex Partec GmbH, Siemens Healthineers, and Bio-Rad Laboratories Inc.

March 28th, 2019, Global Health Innovative Technology Fund announced a total of 2.86 Billion Yen to aid 10 partnerships to research and develop new lifesaving drugs, diagnosis, and vaccines for disorders like Vaccines for Leishmaniasis and Malaria, Schistosomiasis, Malaria, Tuberculosis, Dengue, and Diagnostics.

Jan 2nd, 2019, ERADA Technology Alliance LTD, one of the leaders of innovative, rapid diagnostic solutions for early stage detection of infectious diseases, announced the launch of one of the world’s first diagnostic saliva test for malaria. 

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Ultrasound Devices Market Overview Analysis By Portability, By Display, By Application, By Technology, By End-user Forecast till 2030. Ultrasound Devices Market Size was valued at USD 10.8 billion in 2022. The ultrasound devices market industry is projected to grow from USD 11.2 Billion in 2023 to USD 14.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.10% during the forecast period (2023 - 2030).The report elaborates on the major drivers and restraints for the global ultrasound devices market in detail by analyzing their impact on the market’s trajectory over the forecast period.

The growing demand for ultrasound devices for diagnostic purposes is likely to be the major driver for the global ultrasound devices market over the forecast period. Ultrasound devices work by sending out high-frequency sound waves that provide a picture of the targeted area based on the response of various bodily tissues to the sound waves. Since different tissues react differently to the same sound waves, the technique has become popular in the healthcare sector. The lack of invasion in the use of ultrasound equipment manufacturers has also become a key plus point for the market due to the growing obsession with minimally invasive and noninvasive medical procedures. Therapeutic applications of ultrasound include targeting a specific patch of tissue for stimulation or removal by bombarding it with high-frequency sound waves. This application is also likely to remain a key factor for the global ultrasound devices market’s growth over the forecast period.

Competitive Analysis:

Leading players in the global ultrasound devices market include Siemens AG, GE, Hitachi Ltd., Shimadzu Corporation, Analogic Corporation, Mindray Medical International Ltd., Toshiba Corporation, Samsung Electronics Co. Ltd., and Koninklijke Philips NV.

Regional Analysis:

The Americas is likely to be the major regional for ultrasound devices market research report over the forecast period due to the widespread adoption of advanced ultrasound technology in the region and the growing demand for advanced diagnostic modalities and devices. Europe is also likely to remain a major regional market for ultrasound devices over the forecast period due to the growing healthcare expenditure in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing demand for advanced medical facilities and devices and the increasing investment in hospitals and medical technology.

Segmentation Analysis:

By display, color devices accounted for a largest market share in 2017 compared to its counterpart, black/white ultrasound devices. The former can touch a size of USD 7,509.12 million by 2026, while the latter is likely to show prominent growth by the end of the forecast period.

By application, radiology/general imaging is likely to register highest CAGR during the assessment and likely to dominate the market by 2026. It accounted for the largest market share in 2017 due to its vast medical applications. The rising geriatric populace and incidence of various cancers can spur the segment growth. On the other hand, cardiology is also showing significant growth by 2026.

By technology, diagnostic accounted for the largest market share in 2017 due to the use of 2D ultrasound in women’s health. It is likely to show CAGR over the assessment period and hold significant market share by 2026 due to the continuous advances in imaging and reimbursement schemes for these procedures. On the flip side, therapeutic ultrasound is expected to hold second position by 2026.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Aug 24 '23 · 0 comments · Tags: ultrasound devices market
Pages: «« « ... 2 3 4 5 6 ... » »»